Strychnine-insensitive glycine/nmda sites are altered in two stress models of depression

Polish Journal of Pharmacology

Volumn 50, Issue 4-5, 1998, Pages 365-369

  Nowak, Gabriel ^a   Ossowska, Grazyna ^b   Jopek, Renata ^a   Papp, Mariusz ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Glycine; Models of depression; NMDA sites; Radioligand binding

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DEPRESSION; MALE; NONHUMAN; RAT; STRESS;

ANIMALS; BINDING SITES; CEREBRAL CORTEX; DEPRESSION; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; KYNURENIC ACID; MALE; MODELS, BIOLOGICAL; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS; STRYCHNINE;

EID: 0031737463     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor. Eur. J. Pharmacol., 1991, 206, 149-154.
2. Katz R. J., Roth K. A., Carroll B. J.: Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev., 1981, 5, 247-251.
3. Layer R. T., Popik P., Nowak G., Paul I. A., Trullas R., Skolnick P.: A unified theory of antidepressant action: evidence for adaptation of the N-methyl-D-aspartate (NMDA) receptor following chronic antidepressant treatments. In: Ion Channel Pharmacology, Eds. Soria B., Ceńa V., Oxford University Press, New York, 1998, 438-456.
4. Layer R. T., Popik P., Olds T., Skolnick P.: Anti-depressant-like actions of the polyamine site NMDA antagonist, Eliprodil (SL-82.0715). Pharmacol. Biochem. Behav., 1995, 52, 621-627.
5. Maj J., Rogóż Z., Skuza G., Sowińska H.: The effect of CGP 37849 and CGP 39551, competitive NMDA antagonists, in the forced swimming test. Pol. J. Pharmacol. Pharm., 1992, 44, 337-346.
6. Maj J., Rogöż Z., Skuza G., Sowińska H.: The effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur. Neuropsychopharmacol., 1992, 2, 37-41.
7. Moryl E., Danysz W., Quack G.: Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol. Toxicol., 1993, 72, 394-397.
8. Nowak G.: Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex. Pol. J. Phamacol., 1996, 48, 137-143.
9. Nowak G., Li Y., Paul I. A.: Adaptation of cortical but not hippocampal glutamate-NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol., 1996, 295, 75-85.
10. Nowak G., Redmond A., McNamara M., Paul I. A.: Swim stress increases the potency of glycine at the N-methyl-D-aspartate receptor complex. J. Neurochem., 1995, 64, 925-927.
11. Nowak G., Trullas R., Layer R. T., Skolnick P., Paul I. A.: Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J. Pharmacol. Exp. Ther., 1993, 265, 1380-1386.
12. Ossowska G., Klenk-Majewska B., Szymczyk G.: The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats. J. Physiol. Pharmacol., 1997, 48, 127-135.
13. Papp M., Moryl E.: Similar effect of chronic treatment with imipramine and the NMDA antagonists CGP 37849 and MK-801 in a chronic mild stress model of depression in rats. Eur. J. Neuropsychopharmacol., 1993, 3, 348-349.
14. Papp M., Moryl E.: Antidepressant activity of non-competitive and competitive NMDA antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol., 1994, 263, 1-7.
15. Papp M., Moryl E.: Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression. Eur. J. Pharmacol., 1996, 316, 145-151.
16. Paul I. A, Layer R. T., Skolnick P., Nowak G.: Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. Eur. J. Pharmacol.-Molec. Pharm., 1993, 247, 305-311.
17. Paul I. A., Nowak G., Layer R. T., Popik P., Skolnick P.: Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther., 1994, 269, 95-102.
18. Post R. M., Weiss S. R. B.: Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol. Psychiat., 1992, 32, 469-484.
19. Przegaliński E., Tatarczyńska E., Dereń-Wesołek A.: Antidepressant-like effects of partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology, 1997, 36, 31-37.
20. Skolnick P., Layer R. T., Popik P., Nowak G., Paul I. A., Trullas R.: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry, 1996, 29, 23-26.
21. Smith P. K, Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. I., Provezano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C.: Measurement of protein using bicinchoninic acid. Anal. Biochem., 1985, 150, 76-85.
22. Trullas R., Folio T., Young A., Miller R., Boje K., Skolnick P.: 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol., 1991, 203, 379-385.
23. Trullas R., Skolnick P.: Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol., 1990, 185, 1-10.
24. Van Riezen H., Leonard B. E.: Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. In: Psychopharmacology of Anxiolytics and Antidepressants. Ed. File S. E., Pergamon Press, New York, 1991, 231-250.
25. Willner P., Muscat R., Papp M.: Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev., 1992, 16, 525-534.